Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
15.97
Dollar change
+0.10
Percentage change
0.63
%
IndexNDX, S&P 500 P/E- EPS (ttm)-7.00 Insider Own17.57% Shs Outstand863.67M Perf Week3.37%
Market Cap13.78B Forward P/E5.12 EPS next Y3.12 Insider Trans0.01% Shs Float711.12M Perf Month-4.26%
Income-6037.00M PEG- EPS next Q0.71 Inst Own59.28% Short Float5.97% Perf Quarter-23.22%
Sales144.60B P/S0.10 EPS this Y-19.41% Inst Trans-0.06% Short Ratio3.46 Perf Half Y-38.65%
Book/sh15.63 P/B1.02 EPS next Y-2.74% ROA-6.54% Short Interest42.44M Perf Year-49.40%
Cash/sh0.77 P/C20.62 EPS next 5Y-7.67% ROE-34.82% 52W Range14.62 - 32.53 Perf YTD-38.84%
Dividend Est.1.53 (9.56%) P/FCF- EPS past 5Y- ROI-13.79% 52W High-50.91% Beta0.74
Dividend TTM1.46 (9.14%) Quick Ratio0.32 Sales past 5Y1.35% Gross Margin16.90% 52W Low9.23% ATR (14)0.52
Dividend Ex-DateMay 20, 2024 Current Ratio0.66 EPS Y/Y TTM-92.32% Oper. Margin0.60% RSI (14)46.62 Volatility3.53% 3.24%
Employees331000 Debt/Eq2.57 Sales Y/Y TTM8.48% Profit Margin-4.18% Recom3.05 Target Price21.71
Option/ShortYes / Yes LT Debt/Eq2.25 EPS Q/Q-941.30% Payout- Rel Volume1.50 Prev Close15.87
Sales Surprise3.32% EPS Surprise46.57% Sales Q/Q6.28% EarningsJun 27 BMO Avg Volume12.28M Price15.97
SMA201.22% SMA50-5.81% SMA200-23.21% Trades Volume18,449,007 Change0.63%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Jun-21-24 05:50PM
Jun-20-24 10:00AM
10:00AM
Jun-19-24 07:00AM
06:45AM
06:30AM Loading…
06:30AM
Jun-18-24 05:05PM
04:53PM
03:20PM
11:31AM
04:51AM
Jun-14-24 05:45PM
12:31PM
12:23PM
11:10AM
04:26AM Loading…
04:26AM
Jun-13-24 04:20AM
Jun-12-24 12:06PM
Jun-11-24 09:00AM
Jun-10-24 05:50PM
05:35AM
Jun-08-24 08:52AM
03:30AM
Jun-07-24 06:10PM
01:35PM
Jun-05-24 09:45AM
Jun-04-24 09:00AM
08:00AM
05:21AM
Jun-03-24 05:45PM
06:25AM Loading…
06:25AM
Jun-01-24 03:35AM
May-31-24 10:47AM
06:08AM
May-30-24 08:04PM
03:54PM
May-29-24 07:56PM
06:00PM
05:54PM
01:24PM
09:00AM
09:00AM
May-28-24 09:53AM
09:00AM
08:00AM
06:22AM
May-24-24 05:45PM
12:15PM
09:40AM
May-23-24 11:01AM
May-22-24 06:26PM
05:38PM
08:36AM
07:30AM
May-21-24 04:50PM
05:30AM
05:21AM
May-20-24 05:50PM
09:00AM
May-19-24 11:10AM
06:51AM
May-18-24 09:21AM
May-16-24 04:30PM
05:15AM
May-15-24 09:47AM
09:01AM
08:00AM
May-14-24 05:50PM
11:00AM
09:30AM
06:08AM
May-13-24 06:34PM
05:56PM
05:23PM
04:36PM
04:01PM
01:49PM
01:46PM
01:35PM
12:31PM
12:15PM
11:42AM
11:05AM
10:22AM
09:59AM
May-11-24 03:55AM
May-10-24 09:15AM
May-09-24 10:37AM
09:15AM
May-08-24 05:50PM
04:30PM
09:45AM
May-07-24 11:03AM
09:00AM
06:49AM
May-06-24 04:49PM
03:42PM
May-03-24 04:21PM
05:08AM
04:41AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walgreens Boots Alliance, Inc.10% OwnerMay 22 '24Sale215.121,859,390400,000,15824,418,171May 24 04:05 PM
Bhandari Inderpal SDirectorApr 11 '24Buy18.053,00054,1503,000Apr 15 05:45 PM
Mahajan ManmohanEVP and Global CFOApr 02 '24Buy19.386,000116,280166,969Apr 02 06:40 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 07 '24Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29 '24Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16 '24Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05 '24Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10 '23Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09 '23Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03 '23Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30 '23Buy28.425,172146,98459,050Jul 05 06:57 PM